AAPG · Ascentage Pharma Group International American Depository Shares
View on chart this person other insiders at AAPG
Insiders & Stakes
| Zhai Yifan Chief Medical Officer | ▲ Buy | Option Exercise | 1,193,569 Shares held | 5/21/2026 | View profile |
| Yang Dajun Chairman and CEO | ▲ Buy | Option Exercise | 405,280 Shares held | 5/21/2026 | View profile |
Transaction History
| Zhai Yifan | ▲ Buy | Option Exercise | 92,746 | $0 | 5/21/2026 |
| Zhai Yifan | ▲ Buy | Option Exercise | 95,575 | $0 | 5/21/2026 |
| Yang Dajun | ▲ Buy | Option Exercise | 95,575 | $0 | 5/21/2026 |
| Yang Dajun | ▲ Buy | Option Exercise | 92,746 | $0 | 5/21/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
AAPG shares dip in pre‑market as broader market slides
AAPG American Depository Shares fell in Friday’s pre‑market session. The decline came as the market reacted to Nike’s mixed first‑quarter earnings, which pushed several large stocks lower. The move occurs while the stock is near its $16.96 support level and the RSI is around 41, indicating modest momentum weakness.
AAPG shares dip in pre‑market as broader market slides. AAPG American Depository Shares fell in Friday’s pre‑market session. The decline came as the market reacted to Nike’s mixed first‑quarter earnings, which pushed several large stocks lower. The move occurs while the stock is near its $16.96 support level and the RSI is around 41, indicating modest momentum weakness.